Harbour Investments, Inc. Cara Therapeutics, Inc. Transaction History
Harbour Investments, Inc.
- $2.82 Billion
- Q2 2024
A detailed history of Harbour Investments, Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 525 shares of CARA stock, worth $152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
525
Previous 525
-0.0%
Holding current value
$152
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CARA
# of Institutions
88Shares Held
16.5MCall Options Held
55KPut Options Held
500-
Vanguard Group Inc Valley Forge, PA2.25MShares$652,5960.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.94MShares$561,3580.01% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$493,6110.04% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$451,3120.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.07MShares$309,0670.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $15.6M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...